← Browse by Condition
Medical Condition

vitiligo

Total Trials
5
Recruiting Now
5
Trial Phases
EARLY_Phase 1, Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for vitiligo sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — vitiligo Clinical Trials

How many clinical trials are currently recruiting for vitiligo?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for vitiligo, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for vitiligo?
vitiligo research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a vitiligo clinical trial?
Eligibility criteria for vitiligo trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
1
Phase 4
1
Top Sponsors
Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan 1 trial
Centre Hospitalier Universitaire de Nice 1 trial
Northwestern University 1 trial
CAGE Bio Inc. 1 trial
Al-Azhar University 1 trial

Recruiting Clinical Trials

NCT07398807 EARLY_Phase 1
Recruiting
Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo
Enrollment
40 pts
Location
Pakistan
Sponsor
Combined Military Hospital (CM...
View Trial →
NCT07152626 Phase 2
Recruiting
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
Enrollment
56 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT03577327
Recruiting
The Gut and Skin Microbiome in Vitiligo Disease Progression
Enrollment
100 pts
Location
United States
Sponsor
Northwestern University
View Trial →
NCT07357870 Phase 1
Recruiting
A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo
Enrollment
36 pts
Location
Turkey (Türkiye)
Sponsor
CAGE Bio Inc.
View Trial →
NCT05536856 Phase 4
Recruiting
Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo
Enrollment
60 pts
Location
Egypt
Sponsor
Al-Azhar University
View Trial →

Related Conditions

healthy (1) topical fluorouracil (1) effervescent mixture (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology